Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation

This study has been terminated.
(The clinical use of Campath for transplant patients was temporarily suspended.)
Sponsor:
Collaborators:
Bayer
Gruessner, Rainer, MD
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00177138
First received: September 13, 2005
Last updated: February 5, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2006
  Estimated Primary Completion Date: No date given